| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 2,000 | 1,000 | 1,000 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| INVESTMENT - MS 4921 | 1,203,633 | 1,842,369 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| INVESTMENT IN NEXBIO | AT COST | 571,170 | 571,170 |
| Description | Beginning of Year - Book Value | End of Year - Book Value | End of Year - Fair Market Value |
|---|---|---|---|
| INVESTMENT IN 7 HILLS PHARMA LLC | -90,030 | 13,086 | 13,086 |
| 7 HILLS PHARMA LLC - CONVERTIBLE NOTE | 101,425 | 0 | 0 |
| INVESTMENT IN 4J THERAPEUTICS INC | 200,000 | 355,000 | 355,000 |
| OAKTREE STRATEGIC CREDIT FUND | 0 | 450,000 | 450,382 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| BANK CHARGES | 110 | 110 | 0 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| MORGAN STANLEY #4921 | 24 | 24 | 24 |
| INVESTMENT IN 7 HILLS PHARMA, LLC | -1,377 | -1,377 |
| Description | Amount |
|---|---|
| MISCELLANEOUS | 1,945 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INVESTMENT FEES | 18,446 | 18,446 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOREIGN TAXES | 276 | 276 | 0 | |
| FEDERAL TAXES | 3,000 | 0 | 0 |